1a,25-Dihydroxyvitamin D 3 [1a,25(OH) 2 D 3 ] has antiproliferative, diŠerentiation and apoptosis inducing eŠects on many malignant cells. These properties have raised the possibility of its use as a therapeutic agent in cancer. Our recent studies using stereoisomers of the A-ring of monohydroxylated 19-nor or 2-methyl substituted 1a,25(OH) 2 D 3 have clearly demonstrated that the A-ring analogs that contain 1a-hydroxy or 3b-hydroxy group are potent inducers of HL-60 cell diŠerentiation. In contrast, the A-ring analogs that contain 1b-hydroxy or 3a-hydroxy group are potent stimulators of HL-60 cell apoptosis. It was interesting to note that the analogs could induce diŠerentiation or apoptosis of HL-60 cells on the basis of the stereochemistry of both hydroxy groups at positions 1 and 3 of the A-ring. To further elucidate the possible roles of both the hydroxy groups in regulating cell diŠerentiation and apoptosis, we have synthesized all possible diastereomers of the A-ring of 1a,25(OH) 2 D 3 and examined their molecular mechanism of diŠerentiation and apoptosis-inducing actions of HL-60 cells in vitro. This study shows that diŠerentiation and apoptosis of HL-60 cells are strictly controlled by the stereochemistry of both hydroxy groups at positions 1 and 3 of the A-ring of 1a,25(OH) 2 D 3 , and the proteins responsible for the regulation of cell cycle and mitochondrial membrane potential are the major targets of 1a,25(OH) 2 D 3 analogs. Theseˆndings provide useful information not only for structure-function studies of 1a,25 (OH) 2 D 3 analogs but also for the development of therapeutic agents for the treatment of cancer.
1a,25(OH) 2 D 3 の生理作用は，核内に存在するビ 
